Inogen (INGN) Gains from Investment Securities (2013 - 2024)
Inogen's (INGN) quarterly Gains from Investment Securities came in at $1.2 million in Q4 2024, up 80.0% on a QoQ basis from $650000.0 in Q3 2024.
Inogen (INGN) Gains from Investment Securities (2013 - 2024) Analysis & Trends
Inogen (INGN) has 6 years of Gains from Investment Securities data on file, last reported at $1.2 million in Q4 2024.
- On a quarterly basis, Gains from Investment Securities changed N/A year-over-year to $1.2 million in Q4 2024; TTM through Dec 2024 was $3.0 million, a N/A change from a year earlier, with the FY2024 full-year figure at $3.0 million, down 56.02% from the prior year.
- Gains from Investment Securities for Q4 2024 stood at $1.2 million, up from $650000.0 in the prior quarter.
- Over the last five years, Gains from Investment Securities for INGN reached as high as $1.2 million in Q4 2020 and fell as low as -$13.7 million in Q4 2022.
- Historically, Gains from Investment Securities has averaged -$1.4 million across 4 years, with a median of $59500.0 in 2020.
- Across the five-year window, Gains from Investment Securities slumped 1302.05% in 2021 and soared 137.74% in 2022, its largest moves.
- Year by year, Gains from Investment Securities stood at $1.2 million in 2020, then slumped by 245.53% to -$1.8 million in 2021, then plunged by 671.53% to -$13.7 million in 2022, then jumped by 108.55% to $1.2 million in 2024.
- Per Business Quant data, the three most recent Gains from Investment Securities figures were $1.2 million in Q4 2024, $650000.0 in Q3 2024, and $610000.0 in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Inogen | 173.63 Mn | 63.46 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.17 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 650,000.00 |
| Sep 30, 2024 | 650,000.00 |
| Jun 30, 2024 | 610,000.00 |
| Jun 30, 2024 | 610,000.00 |
| Mar 31, 2024 | 570,000.00 |
| Mar 31, 2024 | 570,000.00 |
| Dec 31, 2022 | -13.69 Mn |
| Dec 31, 2022 | -13.69 Mn |
| Sep 30, 2022 | -288,000.00 |
| Sep 30, 2022 | -288,000.00 |
| Jun 30, 2022 | -2.04 Mn |
| Jun 30, 2022 | -2.04 Mn |
| Mar 31, 2022 | 630,000.00 |
| Mar 31, 2022 | 630,000.00 |
| Dec 31, 2021 | -1.77 Mn |
| Dec 31, 2021 | -1.77 Mn |
| Sep 30, 2021 | -2.05 Mn |
| Sep 30, 2021 | -2.05 Mn |